Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Spooner, Ellen ^a   McLaughlin, Brooke M ^a   Lepow, Talya ^a   Durns, Tyler A ^a   Randall, Justin ^a   Upchurch, Cameron ^a   Miller, Katherine ^a   Campbell, Erin M ^a   Fares, Hanna ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TRPML1; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MORQUIO SYNDROME; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; TWO HYBRID SYSTEM; VALIDATION PROCESS; YEAST;

ANIMALS; BLOTTING, WESTERN; CELL LINE; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; MICROSCOPY, CONFOCAL; MUCOLIPIDOSES; MUTATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEINS; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84873929726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056780     Document Type: Article

References (53)

1. Altarescu G, Sun M, Moore DF, Smith JA, Wiggs EA, et al. (2002) The neurogenetics of mucolipidosis type IV. Neurology 59: 306-313.
2. Bach G, (2001) Mucolipidosis type IV. Mol Genet Metab 73: 197-203.
3. Bargal R, Avidan N, Ben-Asher E, Olender Z, Zeigler M, et al. (2000) Identification of the gene causing mucolipidosis type IV. Nat Genet 26: 118-123.
4. Bassi MT, Manzoni M, Monti E, Pizzo MT, Ballabio A, et al. (2000) Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am J Hum Genet 67: 1110-1120.
5. Sun M, Goldin E, Stahl S, Falardeau JL, Kennedy JC, et al. (2000) Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet 9: 2471-2478.
6. Cantiello HF, Montalbetti N, Goldmann WH, Raychowdhury MK, Gonzalez-Perrett S, et al. (2005) Cation channel activity of mucolipin-1: the effect of calcium. Pflugers Arch 451: 304-312.
7. Dong XP, Cheng X, Mills E, Delling M, Wang F, et al. (2008) The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455: 992-996.
8. Eichelsdoerfer JL, Evans JA, Slaugenhaupt SA, Cuajungco MP, (2010) Zinc dyshomeostasis is linked with the loss of mucolipidosis IV-associated TRPML1 ion channel. J Biol Chem 285: 34304-34308.
9. Kiselyov K, Chen J, Rbaibi Y, Oberdick D, Tjon-Kon-Sang S, et al. (2005) TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J Biol Chem 280: 43218-43223.
10. LaPlante JM, Falardeau J, Sun M, Kanazirska M, Brown EM, et al. (2002) Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett 532: 183-187.
11. Pryor PR, Reimann F, Gribble FM, Luzio JP, (2006) Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic 7: 1388-1398.
12. Vergarajauregui S, Oberdick R, Kiselyov K, Puertollano R, (2008) Mucolipin 1 channel activity is regulated by protein kinase A-mediated phosphorylation. Biochem J 410: 417-425.
13. Bach G, Webb MB, Bargal R, Zeigler M, Ekstein J, (2005) The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations. Hum Mutat 26: 591.
14. Schiffmann R, Slaugenhaupt SA, Smith J, Goldin E (1993) Mucolipidosis IV. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA).
15. Curcio-Morelli C, Zhang P, Venugopal B, Charles FA, Browning MF, et al. (2009) Functional multimerization of mucolipin channel proteins. J Cell Physiol 222: 328-335.
16. Zeevi DA, Lev S, Frumkin A, Minke B, Bach G, (2010) Heteromultimeric TRPML channel assemblies play a crucial role in the regulation of cell viability models and starvation-induced autophagy. J Cell Sci 123: 3112-3124.
17. Bargal R, Bach G, (1997) Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J Inherit Metab Dis 20: 625-632.
18. LaPlante JM, Ye CP, Quinn SJ, Goldin E, Brown EM, et al. (2004) Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem Biophys Res Commun 322: 1384-1391.
19. Thompson EG, Schaheen L, Dang H, Fares H, (2007) Lysosomal trafficking functions of mucolipin-1 in murine macrophages. BMC Cell Biol 8: 54.
20. Vergarajauregui S, Martina JA, Puertollano R, (2009) Identification of the penta-EF-hand protein ALG-2 as a Ca2+-dependent interactor of mucolipin-1. J Biol Chem 284: 36357-36366.
21. Venugopal B, Browning MF, Curcio-Morelli C, Varro A, Michaud N, et al. (2007) Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Am J Hum Genet 81: 1070-1083.
22. Zeigler M, Bargal R, Suri V, Meidan B, Bach G, (1992) Mucolipidosis type IV: accumulation of phospholipids and gangliosides in cultured amniotic cells. A tool for prenatal diagnosis. Prenat Diagn 12: 1037-1042.
23. LaPlante JM, Sun M, Falardeau J, Dai D, Brown EM, et al. (2006) Lysosomal exocytosis is impaired in mucolipidosis type IV. Mol Genet Metab 89: 339-448.
24. Chen CS, Bach G, Pagano RE, (1998) Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc Natl Acad Sci U S A 95: 6373-6378.
25. Kiselyov K, Jennigs JJ Jr, Rbaibi Y, Chu CT, (2007) Autophagy, mitochondria and cell death in lysosomal storage diseases. Autophagy 3: 259-262.
26. Vergarajauregui S, Puertollano R, (2008) Mucolipidosis type IV: the importance of functional lysosomes for efficient autophagy. Autophagy 4: 832-834.
27. Venugopal B, Mesires NT, Kennedy JC, Curcio-Morelli C, Laplante JM, et al. (2009) Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol 219: 344-353.
28. Jennings JJ Jr, Zhu JH, Rbaibi Y, Luo X, Chu CT, et al. (2006) Mitochondrial aberrations in mucolipidosis Type IV. J Biol Chem 281: 39041-39050.
29. Vergarajauregui S, Martina JA, Puertollano R, (2011) LAPTMs regulate lysosomal function and interact with mucolipin 1: new clues for understanding mucolipidosis type IV. J Cell Sci 124: 459-468.
30. Thaminy S, Miller J, Stagljar I, (2004) The split-ubiquitin membrane-based yeast two-hybrid system. Methods in molecular biology 261: 297-312.
31. Dang H, Klokk TI, Schaheen B, McLaughlin BM, Thomas AJ, et al. (2011) Derlin-dependent retrograde transport from endosomes to the golgi apparatus. Traffic 12: 1417-1431.
32. Chen EI, Hewel J, Felding-Habermann B, Yates JR, 3rd (2006) Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol Cell Proteomics 5: 53-56.
33. Liu H, Lin D, Yates JR, 3rd (2002) Multidimensional separations for protein/peptide analysis in the post-genomic era. Biotechniques 32passim.
34. Schaheen B, Dang H, Fares H, (2009) Derlin-dependent accumulation of integral membrane proteins at cell surfaces. J Cell Sci 122: 2228-2239.
35. Craig R, Beavis RC, (2004) TANDEM: matching proteins with tandem mass spectra. Bioinformatics 20: 1466-1467.
36. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.
37. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
38. Manzoni M, Monti E, Bresciani R, Bozzato A, Barlati S, et al. (2004) Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization. FEBS Lett 567: 219-224.
39. Nishida E, Muneyuki E, Maekawa S, Ohta Y, Sakai H, (1985) An actin-depolymerizing protein (destrin) from porcine kidney. Its action on F-actin containing or lacking tropomyosin. Biochemistry 24: 6624-6630.
40. Lorente-Rodriguez A, Barlowe C, (2011) Entry and exit mechanisms at the cis-face of the Golgi complex. Cold Spring Harb Perspect Biol 3.
41. Matern H, Yang X, Andrulis E, Sternglanz R, Trepte HH, et al. (2000) A novel Golgi membrane protein is part of a GTPase-binding protein complex involved in vesicle targeting. EMBO J 19: 4485-4492.
42. Mairhofer M, Steiner M, Salzer U, Prohaska R, (2009) Stomatin-like protein-1 interacts with stomatin and is targeted to late endosomes. J Biol Chem 284: 29218-29229.
43. Spiering D, Hodgson L, (2011) Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr 5: 170-180.
44. Bright NA, Gratian MJ, Luzio JP, (2005) Endocytic delivery to lysosomes mediated by concurrent fusion and kissing events in living cells. Curr Biol 15: 360-365.
45. Treusch S, Knuth S, Slaugenhaupt SA, Goldin E, Grant BD, et al. (2004) Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc Natl Acad Sci U S A 101: 4483-4488.
46. Chun DK, McEwen JM, Burbea M, Kaplan JM, (2008) UNC-108/Rab2 regulates postendocytic trafficking in Caenorhabditis elegans. Mol Biol Cell 19: 2682-2695.
47. Lu Q, Zhang Y, Hu T, Guo P, Li W, et al. (2008) C. elegans Rab GTPase 2 is required for the degradation of apoptotic cells. Development 135: 1069-1080.
48. Hilpela P, Vartiainen MK, Lappalainen P, (2004) Regulation of the actin cytoskeleton by PI(4,5)P2 and PI(3,4,5)P3. Curr Top Microbiol Immunol 282: 117-163.
49. Blazer-Yost BL, Nofziger C, (2005) Phosphoinositide lipid second messengers: new paradigms for transepithelial signal transduction. Pflugers Arch 450: 75-82.
50. Oude Weernink PA, Schmidt M, Jakobs KH, (2004) Regulation and cellular roles of phosphoinositide 5-kinases. Eur J Pharmacol 500: 87-99.
51. Waselle L, Gerona RR, Vitale N, Martin TF, Bader MF, et al. (2005) Role of phosphoinositide signaling in the control of insulin exocytosis. Mol Endocrinol 19: 3097-3106.
52. Yu M, Kasai K, Nagashima K, Torii S, Yokota-Hashimoto H, et al. (2007) Exophilin4/Slp2-a targets glucagon granules to the plasma membrane through unique Ca2+-inhibitory phospholipid-binding activity of the C2A domain. Mol Biol Cell 18: 688-696.
53. Di Paolo G, Moskowitz HS, Gipson K, Wenk MR, Voronov S, et al. (2004) Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature 431: 415-422.